LGC 40863: one of the pyrimidinyl-oxy-benzoate herbicides; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 178117 |
| SCHEMBL ID | 118872 |
| MeSH ID | M0290458 |
| Synonym |
|---|
| pyribenzoxim |
| (benzhydrylideneamino) 2,6-bis[(4,6-dimethoxypyrimidin-2-yl)oxy]benzoate |
| pyribenzoxim [iso:bsi] |
| unii-vbd478968p |
| vbd478968p , |
| o-(2,6-bis((4,6-dimethoxy-2-pyrimidinyl)oxy)benzoyl)oxime |
| benzophenone o-(2,6-bis(4,6-dimethoxypyrimidin-2-yloxy)benzoyl)oxime |
| lgc 40863 |
| lgc-40863 |
| pyanchor |
| 168088-61-7 |
| benzophenone o-(2,6-bis((4,6-dimethoxypyrimidin-2-yl)oxy)benzoyl) oxime |
| AKOS015913761 |
| pyribenzoxim [iso] |
| kiljabi gold |
| methanone, diphenyl-, o-(2,6-bis((4,6-dimethoxy-2-pyrimidinyl)oxy)benzoyl)oxime |
| diphenylmethanone o-(2,6-bis((4,6-dimethoxy-2-pyrimidinyl)oxy)benzoyl)oxime |
| SCHEMBL118872 |
| DTXSID2057996 |
| A1-01910 |
| pyribenzoxim, pestanal(r), analytical standard |
| AS-73635 |
| (diphenylmethylidene)amino 2,6-bis[(4,6-dimethoxypyrimidin-2-yl)oxy]benzoate |
| benzophenone o-(2,6-bis((4,6-dimethoxypyrimidin-2-yl)oxy)benzoyl)oxime |
| pyribenzoxim 100 microg/ml in acetonitrile |
| diphenylmethanone o-(2,6-bis((4,6-dimethoxypyrimidin-2-yl)oxy)benzoyl) oxime |
| mfcd09751192 |
| OVXMBIVWNJDDSM-UHFFFAOYSA-N |
| methanone, diphenyl-, o-[2,6-bis[(4,6-dimethoxy-2-pyrimidinyl)oxy]benzoyl]oxime |
| Q27291746 |
| pyanchor; o-(2,6-bis(4,6-dimethoxypyrimidin-2-yloxy)benzoyl)oxime benzophenone |
| A882195 |
| CS-0065630 |
| HY-116489 |
| Excerpt | Reference | Relevance |
|---|---|---|
| " The elimination half-lives of radioactivity from tissues was in the range of 7 to 77 h and Tmax values of 12, 24 and 12 h were observed for blood, liver and kidney, respectively." | ( In vivo pharmacokinetics of pyribenzoxim in rats. Kang, SH; Kim, JH; Koo, SJ; Lee, HS; Liu, KH; Moon, JK; Sung, HJ, 2001) | 0.31 |
| Excerpt | Reference | Relevance |
|---|---|---|
| " These results demonstrate that the bioavailability of LGC-40863 is negligible." | ( Pharmacokinetic analysis for assessing developmental toxicity of a new synthetic acetolactate synthase inhibitor, LGC-40863, in rats. Ahn, SC; Cho, JH; Chung, MK; Han, SS; Roh, JK; Shim, HO; Shin, HC, 1998) | 0.3 |
| Excerpt | Relevance | Reference |
|---|---|---|
| "2% at the lowest dosage level but not at higher dosages." | ( Pharmacokinetic analysis for assessing developmental toxicity of a new synthetic acetolactate synthase inhibitor, LGC-40863, in rats. Ahn, SC; Cho, JH; Chung, MK; Han, SS; Roh, JK; Shim, HO; Shin, HC, 1998) | 0.3 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||